Revance Therapeutics reported $8.04M in Trade Creditors for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
Adamas Pharmaceuticals ADMS:US 4.21M 1.74M
Aerie Pharmaceuticals AERI:US $ 8.08M 0.64M
ALKERMES ALKS:US 36.88M 4.08M
Biodelivery Sciences International BDSI:US $ 7.03M 2.96M
Bristol Myers Squibb BMY:US $ 2695M 914M
Coherus Biosciences CHRS:US $ 45.71M 31.14M
Eli Lilly And LLY:US $ 1566.8M 31M
Endo International Ordinary Shares ENDP:US $ 111.04M 7.2M
Flexion Therapeutics FLXN:US $ 7.49M 2.02M
Gw Pharmaceuticals GWPH:US $ 16.67M 5.2M
Horizon Pharma HZNP:US $ 50.72M 1.22M
JAZZ PHA JAZZ:US $ 63.82M 1.01M
Pacira Pharmaceuticals PCRX:US $ 7.9M 4.28M
Procter & Gamble PG:US $ 14223M 503M
Revance Therapeutics RVNC:US $ 8.04M 138K
Teva Pharmaceutical Industries TEVA:US $ 1514M 37M
Zogenix ZGNX:US $ 12.11M 1.28M